Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
William R. ShepardDirector | Cme GroupCME | Open-market buy | 09/25 | 09/28 | 292.55 sh | $268.76 | $78,625.74 | +0.1% |
Cme GroupCME | Open-market buy | 06/25 | 06/29 | 339.1 sh2 trades | $230.57avg. | $78,186.28 | No record | |
Piell Hilda HarrisSr MD & Chief HR Officer | Cme GroupCME | Open-market sale | 05/18 | 05/19 | 5,753 sh | $304.63 | $1,752,536.39 | −17.2% |
Cme GroupCME | Open-market sale | 05/15 | 05/18 | 35,000 sh2 trades | $298.51avg. | $10,447,865.76 | −38.6% | |
Cme GroupCME | Open-market buy | 03/26 | 03/30 | 1,469.84 sh2 trades | $297.38avg. | $437,101.02 | No record | |
Jonathan L. MarcusSr MD General Counsel | Cme GroupCME | Open-market sale10b5-1 plan · Amendment | 03/17 | 03/23 | 3,291 sh | $313.37 | $1,031,300.67 | −31.4% |
Jonathan L. MarcusSr MD General Counsel | Cme GroupCME | Open-market sale10b5-1 plan | 03/17 | 03/19 | 3,291 sh | $333.37 | $1,097,120.67 | −31.4% |
Vroman KenChief Transformation Officer | Cme GroupCME | Open-market sale | 03/12 | 03/12 | 5,160 sh | $309.00 | $1,594,440 | −25.7% |
Elizabeth A. CookDirector | Cme GroupCME | Open-market sale | 03/06 | 03/09 | 1,000 sh | $320.00 | $320,000 | −5.3% |
Bryan T. DurkinDirector | Cme GroupCME | Open-market sale | 02/23 | 02/23 | 4,200 sh | $309.65 | $1,300,530 | −8.9% |
Martin J. GepsmanDirector | Cme GroupCME | Open-market sale | 02/20 | 02/20 | 300 sh | $305.90 | $91,770 | −1.2% |
Dennis SuskindDirector | Cme GroupCME | Open-market sale | 02/06 | 02/09 | 748 sh | $300.00 | $224,400 | −21.7% |
Cme GroupCME | Open-market buy | 25/12/30 | 01/02 | 262.27 sh2 trades | $278.37avg. | $73,008.1 | No record | |
Cme GroupCME | Open-market sale | 25/12/11 | 25/12/15 | 25,000 sh2 trades | $269.55avg. | $6,738,815.45 | −27.5% | |
Cme GroupCME | Open-market sale | 25/11/20 | 25/11/21 | 7,200 sh2 trades | $275.67avg. | $1,984,798.26 | −50.6% | |
Harold Eugene Ford Jr.Director | Cme GroupCME | Open-market sale | 25/11/03 | 25/11/04 | 1,000 sh | $263.53 | $263,530 | −47.8% |
Cme GroupCME | Open-market buy | 25/09/25 | 25/09/26 | 274.04 sh2 trades | $265.19avg. | $72,673.02 | No record | |
Jonathan L. MarcusSr MD General Counsel | Cme GroupCME | Open-market sale10b5-1 plan | 25/09/18 | 25/09/18 | 392 sh | $262.00 | $102,704 | −4.8% |
Timothy Francis McCourtSr MD Global Head Equity & FX | Cme GroupCME | Open-market sale | 25/09/16 | 25/09/17 | 379 sh | $259.83 | $98,475.57 | −3.8% |
Jonathan L. MarcusSr MD General Counsel | Cme GroupCME | Open-market sale10b5-1 plan | 25/09/16 | 25/09/17 | 376 sh | $258.96 | $97,368.96 | −4.2% |